Sinopharm
1099.HK
#1980
Rank
$5.81 B
Marketcap
$1.86
Share price
-5.19%
Change (1 day)
-27.91%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2021: $81.77 B

According to Sinopharm's latest financial reports the company's current revenue (TTM) is $81.77 B. In 2021 the company made a revenue of $81.77 B an increase over the years 2020 revenue that were of $69.97 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2021

Annual revenue

Year Revenue Change
2021$81.77 B16.85%
2020$69.97 B14.95%
2019$60.87 B21.52%
2018$50.09 B17.65%
2017$42.58 B14.55%
2016$37.17 B6.12%
2015$35.02 B8.38%
2014$32.32 B17.22%
2013$27.57 B26.6%
2012$21.77 B33.9%
2011$16.26 B55.34%
2010$10.47 B52.02%
2009$6.88 B22.89%
2008$5.60 B31.41%
2007$4.26 B40.26%
2006$3.04 B